Table 1. Clinical characteristics between the low and high AUC groups at baseline.
| All (n= 64) | Low AUC (n= 32) | High AUC (n= 32) | P | |
|---|---|---|---|---|
| Age (year) | 67±10 | 69±10 | 65±11 | 0.088 |
| Male (%) | 50 (78.1) | 26 (81.3) | 24 (75.0) | 0.545 |
| Smoking (%) | 28 (43.8) | 13 (40.6) | 15 (46.9) | 0.614 |
| HT (%) | 63 (98.4) | 31 (96.9) | 32 (100) | 0.500 |
| DM (%) | 33 (51.6) | 14 (43.8) | 19 (59.4) | 0.211 |
| DLp (%) | 21 (32.8) | 9 (28.1) | 12 (37.5) | 0.424 |
| SBP (mmHg) | 146.2±20.8 | 145.8±17.3 | 146.4±23.8 | 0.910 |
| DBP (mmHg) | 72.7±13.5 | 73.1±11.3 | 72.3±15.3 | 0.807 |
| ACE-I/ARB (%) | 29 (45.3) | 15 (46.9) | 14 (43.8) | 0.896 |
| Statin (%) | 23 (35.9) | 12 (37.5) | 11 (34.4) | 0.872 |
| LC (%) | 29 (45.3) | 12 (37.5) | 17 (53.1) | 0.209 |
| CC (%) | 35 (54.7) | 20 (62.5) | 15 (46.9) | 0.209 |
| Sevelamer (%) | 4 (6.3) | 2 (6.3) | 2 (6.3) | 0.650 |
| Bixalomer (%) | 5 (7.8) | 2 (6.3) | 3 (9.4) | 0.555 |
| Vitamin D (%) | 31 (48.4) | 15 (46.9) | 16 (50.0) | 0.487 |
| Warfarin (%) | 3 (4.7) | 2 (6.3) | 1 (3.1) | 0.500 |
| Hb (g/dL) | 10.8±0.9 | 10.8±0.9 | 10.7±0.8 | 0.785 |
| cCa (mg/dL) | 8.9±0.6 | 8.9±0.6 | 8.8±0.6 | 0.553 |
| P (mg/dL) | 5.0±1.2 | 4.4±1.1 | 5.6±1.0 | ＜0.001 |
| Albumin (g/dL) | 3.8±0.3 | 3.8±0.3 | 3.8±0.3 | 0.900 |
| Intact PTH (pg/mL) | 152.8 (63.4–265.5) | 138.8 (57.6–226.1) | 173.0 (79.2–436.9) | 0.398 |
| CACS | 540.3 (149.7–1119.1) | 441.0 (109.3–1234.7) | 625.6 (185.1–1077.9) | 0.909 |
| CVCS | 2.0 (0.0–3.0) | 2.0 (0.5–4.0) | 2.0 (0.0–2.5) | 0.231 |
AUC, area under the curve; HT, hypertension; DM, diabetes mellitus; DLp, dyslipidemia; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; Hb, hemoglobin; cCa, corrected calcium; P, phosphate; PTH, parathyroid hormone; CACS, coronary artery calcium score; CVCS, cardiac valvular calcification score; CC, calcium carbonate; LC, lanthanum carbonate
Values are presented as mean±SD or median (interquartile range).